RAP1A and urinary bladder carcinoma: Here, we found that YM529 blocks the prenylation of Rap1A and Ras in bladder cancer cells, inhibits the growth of bladder cancer cells in vitro (Figures 1A, B and 2A), in a dose- and time-dependent manner, and clearly induces apoptosis in bladder cancer cells (Figure 2B).